Stephen I. Rennard

Active 1979–2025

226
Papers
48,015
Citations
118
h-index
225
i10-index

Citations

Citations per year for Stephen I. Rennard1979: 3 citations1980: 29 citations1981: 72 citations1982: 89 citations1983: 86 citations1984: 95 citations1985: 97 citations1986: 111 citations1987: 96 citations1988: 109 citations1989: 93 citations1990: 108 citations1991: 85 citations1992: 63 citations1993: 67 citations1994: 58 citations1995: 70 citations1996: 69 citations1997: 59 citations1998: 105 citations1999: 123 citations2000: 127 citations2001: 121 citations2002: 163 citations2003: 184 citations2004: 206 citations2005: 197 citations2006: 273 citations2007: 251 citations2008: 245 citations2009: 269 citations2010: 282 citations2011: 354 citations2012: 379 citations2013: 369 citations2014: 399 citations2015: 347 citations2016: 317 citations2017: 346 citations2018: 306 citations2019: 1,137 citations2020: 1,106 citations2021: 1,024 citations2022: 800 citations2023: 608 citations2024: 860 citations2025: 375 citations2026: 11 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,272 citing papers, 27.1% of this breakdownUnited Kingdom: 1,774 citing papers, 11.3% of this breakdownGermany: 786 citing papers, 5% of this breakdownCanada: 771 citing papers, 4.9% of this breakdownChina: 757 citing papers, 4.8% of this breakdownItaly: 664 citing papers, 4.2% of this breakdownNetherlands: 650 citing papers, 4.1% of this breakdownSpain: 635 citing papers, 4% of this breakdownAustralia: 486 citing papers, 3.1% of this breakdownFrance: 435 citing papers, 2.8% of this breakdownJapan: 376 citing papers, 2.4% of this breakdownSweden: 364 citing papers, 2.3% of this breakdown
0%27.1%Other 24%

Fields

  • Medicine75%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Immunology and Microbiology2.8%
  • Neuroscience1.4%
  • Environmental Science1.2%
  • Health Professions1%
  • Other3.8%

Topics

  • Chronic Obstructive Pulmonary Disease (COPD) Research15.2%
  • Asthma and respiratory diseases6.5%
  • Respiratory Support and Mechanisms4.5%
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis2.9%
  • Respiratory and Cough-Related Research2.4%
  • Cell Adhesion Molecules Research2.2%
  • Other66.3%

Coauthors

All papers

Open in search
  1. Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 2,979

  2. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 690

  3. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials

    Authors: , , , , , , - The Lancet Respiratory Medicine 2018 cited by 440

  4. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2004 cited by 4,434

  5. Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype

    Authors: , , , , , , , , , , , , , , , , , - PLoS ONE 2012 cited by 850

  6. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2015 cited by 258

  7. Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook

    Authors: , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 cited by 104

  8. Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David A. Lomas, Stephanie J. London, Deborah A. Meyers, George O'connor, Stephen I. Rennard, David A. Schwartz, Paweł Śliwiński, David Sparrow, David P. Strachan, Ruth Tal‐Singer, Yohannes Tesfaigzi, Jørgen Vestbo, Judith M. Vonk, Jae‐Joon Yim, Xiaobo Zhou, Yohan Bossé, Ani Manichaikul, Lies Lahousse, Edwin K. Silverman, H. Marike Boezen, Louise V. Wain, Martin D. Tobin, Brian D. Hobbs, Michael H. Cho, Nick Shrine, Anna L. Guyatt, Chiara Batini, Jing Hua Zhao, Matthias Wielscher, Understanding Society Scientific Group, Stefan Weiß, Katherine A. Kentistou, James P. Cook, Jennie Hui, Stefan Karrasch, Medea Imboden, Sarah E. Harris, Jonathan Marten, Stefan Enroth, Shona M. Kerr, Ida Surakka, Véronique Vitart, Terho Lehtimäki, Ralf Ewert, Christian Gieger, Georg Homuth, Peter K. Joshi, Claudia Langenberg, Lars Lind, Jian’an Luan, Anubha Mahajan, Alison D. Murray, David J. Porteous, Rajesh Rawal, Blair H. Smith, Paul R. H. J. Timmers, Olli Raitakari, Mika Kähönen, Ozren Polašek, Ulf Gyllensten, Igor Rudan, Ian J. Deary, Nicole Probst‐Hensch, Holger Schulz, Alan L. James, James F. Wilson, Beate Stubbe, Eleftheria Zeggini, Marjo‐Riitta Järvelin, Nick Wareham and 89 more - Nature Genetics 2019 cited by 423

  9. Changes in Forced Expiratory Volume in 1 Second over Time in COPD

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 958

  10. At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 280

  11. Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS): Table 1

    Authors: , , , , , , , , , , - Thorax 2013 cited by 402

  12. SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs

    Authors: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2016 cited by 255

  13. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Russell P. Bowler, Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 cited by 318

  14. Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels

    Authors: , , , , , , , , , , , , - American Journal of Physiology-Lung Cellular and Molecular Physiology 2014 cited by 221

  15. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elizabeth E. Carretta, Stephanie A. Christenson, Alejandro P Comellas, Christopher B. Cooper, David Couper, Gerard J. Criner, Ronald G. Crystal, Jeffrey L. Curtis, Claire M. Doerschuk, Mark T. Dransfield, Christine M. Freeman, MeiLan K. Han, Nadia N. Hansel, Annette T. Hastie, Eric A. Hoffman, Robert J. Kaner, Richard E. Kanner, Eric C. Kleerup, Jerry A. Krishnan, Lisa M. LaVange, Stephen C. Lazarus, Fernando J. Martínez, Deborah A. Meyers, John D. Newell, Elizabeth C. Oelsner, Wanda K. O’Neal, Robert Paine, Nirupama Putcha, Stephen I. Rennard, Donald P. Tashkin, Mary Beth Scholand, J. Michael Wells, Robert A. Wise, Prescott G. Woodruff - The Lancet Respiratory Medicine 2017 cited by 317

  16. Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2012 cited by 430

  17. Early chronic obstructive pulmonary disease: definition, assessment, and prevention

    Authors: , - The Lancet 2015 cited by 269

  18. Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith García‐Aymerich, Thierry Troosters - Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation 2021 cited by 95

  19. Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease

    Authors: , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2020 cited by 101

  20. Quantitative Computed Tomography Measures of Pectoralis Muscle Area and Disease Severity in Chronic Obstructive Pulmonary Disease. A Cross-Sectional Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the American Thoracic Society 2014 cited by 248

  21. Reconsidering the Utility of Race-Specific Lung Function Prediction Equations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 cited by 109

  22. Small airway determinants of airflow limitation in chronic obstructive pulmonary disease

    Authors: , , , , , , , , , - Thorax 2021 cited by 56

  23. Outcomes for COPD pharmacological trials: from lung function to biomarkers

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2008 cited by 857

  24. Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthijs Oudkerk, Harry J.M. Groen, Nicholas Locantore, Ruth Tal‐Singer, Stephen I. Rennard, Jørgen Vestbo, Wim Timens, Peter D. Paré, Jeanne C. Latourelle, Josée Dupuis, George O'connor, Jemma B. Wilk, Woo Jin Kim, Mi Kyeong Lee, Yeon‐Mok Oh, Judith M. Vonk, Harry J. de Koning, Shuguang Leng, Steven A. Belinsky, Yohannes Tesfaigzi, Ani Manichaikul, Xin‐Qun Wang, Stephen S. Rich, R. Graham Barr, David Sparrow, Augusto A. Litonjua, Per Bakke, Amund Gulsvik, Lies Lahousse, Guy Brusselle, Bruno H. Stricker, André G. Uitterlinden, Elizabeth J. Ampleford, Eugene R. Bleecker, Prescott G. Woodruff, Deborah A. Meyers, Dandi Qiao, David A. Lomas, Jae‐Joon Yim, Deog Kyeom Kim, I Hawryłkiewicz, Paweł Śliwiński, Megan Hardin, Tasha E. Fingerlin, David A. Schwartz, Dirkje S. Postma, William MacNee, Martin D. Tobin, Edwin K. Silverman, H. Marike Boezen, Michael H. Cho - Nature Genetics 2017 cited by 442